2012 CME Annual meeting in multiple sclerosis MS: from disease management to patient management Valencia, Spain 18-19 May 2012
Dear Colleague On behalf of the Serono Symposia International Foundation we are delighted to welcome you to the 2012 annual continuing medical education (CME) accredited meeting: MS: from disease management to patient management. At this meeting, leading international experts will come together to discuss current and future approaches to the treatment of multiple sclerosis (MS). You will also have the opportunity to earn CME credits. This interactive meeting is divided into four sessions. Session 1 will cover the pharmacological targets of current and possible future therapies, and the requirement for close safety monitoring of newer therapies. In session 2 we will detail how the neurologist can best use the tools available for optimal diagnosis of MS and prediction of disease course. Session 3 will focus on current and future techniques to predict and monitor response to treatment, and in session 4 we will discuss the clinical management of MS, the relationship with the patient and how this can affect treatment adherence. Case studies will be presented, offering you the opportunity to discuss various aspects of clinical practice with the panel of experts. The aims of the 2012 annual conference are to provide an update on the latest understanding of MS pathophysiology and the mechanisms of action of current drugs, to discuss how best to diagnose patients and then predict and monitor treatment response, and to provide guidance on how best to ensure patients get optimal benefit from treatment. We anticipate that this programme will provide valuable updates for the clinician, and will stimulate engaging and enlightened debate on many of the complex issues surrounding the management of patients with MS. We hope that you will be able to join us and we look forward to your active participation. Yours sincerely, David Bates Newcastle upon Tyne, UK Xavier Montalban Barcelona, Spain All Serono Symposia International Foundation programs are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. All Serono Symposia International Foundation programs are made possible thanks to educational grants received from: Centre d Esclerosi Multiple de Catalunya, ComtecMed, Congrex Sweden, Congrex Switzerland, Cryo-Save, Datanalysis, Esaote, European Society of Endocrinology, Fondazione Humanitas, Fundación IVI, ISFP International Society for Fertility Preservation, ISMH International Society of Men s Health, K.I.T.E., Merck Serono, Sanofi-Aventis, University of Catania, Vall d Hebron University Hospital.
AIM OF THE CONFERENCE LEARNING OBJECTIVES TARGET AUDIENCE ACCREDITATION Research into the pathophysiology of multiple sclerosis (MS) and the mechanism of action of new drugs has, in recent years, produced a virtuous circle offering ever-new insights, enhancing our understanding of the disease and allowing optimization of treatment. The 2012 Serono Symposia International Foundation (SSIF) annual meeting will provide a review of these insights and offer the opportunity to discuss how to translate this increasing knowledge of management improvements for individual patients. By attending the conference, participants will: be updated on MS pathophysiology and modes of action of individual drugs discuss the use of standardized diagnostic criteria in daily practice improve their skills in sharing information with patients to increase adherence understand present and future biomarkers of response to treatment. Clinicians involved in MS management. An application has been made to the EACCME for CME accreditation of the MS: from disease management to patient management conference, to be held on 18 19 May 2012 in Valencia, Spain. The official language of the conference will be English. REGISTRATION The full registration fee is 400,00 euro. For any registration requirements please contact Debora Urbinelli c/o Meridiano Congress International Tel. +39 (0)6 88 595 232 - Fax +39 (0)6 88 595 234 E-mail: d.urbinelli@meridiano.it 1
VENUE CHAIRS The conference will take place at: Meliá Valencia Palacio de Congresos Avenida Cortes Valencianas 52 Valencia, Spain David Bates Department of Neurology Royal Victoria Infirmary Newcastle upon Tyne, UK Xavier Montalban Multiple Sclerosis Centre of Catalonia Unit of Clinical Neuroimmunology Vall d Hebron University Hospital Barcelona, Spain SCIENTIFIC SECRETARIAT ORGANIZING SECRETARIAT Serono Symposia International Foundation Salita San Nicola da Tolentino, 1/B 00187 - Rome, Italy Senior Project Manager, Neurology Team Leader: Serena Dell Ariccia Associate Project Manager: Alessia Addessi Phone: +39 06 420 413 251/591 Fax: +39 06 420 413 677 info@seronosymposia.org Meridiano Congress International Via Mentana, 2/B 00185 - Rome, Italy Congress Coordinator: Debora Urbinelli Phone: +39 06 88 595 232 Mail: d.urbinelli@meridiano.it 2
Day 1 Friday, 18 May, 2012 08.15 SSIF Opening G. Comi (Italy) 08.30 Local welcome 08.45 Welcome and introduction D. Bates (UK) and X. Montalban (Spain) SCIENTIFIC PROGRAMME SESSION I Pharmacological targets and evolving pathophysiological concepts D. Bates (UK) 09.00 L1 Improving understanding of mechanism of action of immunomodulatory drugs B. Kieseier (Germany) 09.30 L2 Neuroprotection and neuroregeneration: the promising targets R. Gold (Germany) 10.00 L3 Resetting the immune system: stem cell transplantation A. Uccelli (Italy) 10.30 L4 Drug profile and efficacy G. Comi (Italy) 11.00 L5 Safety assessment in practice P. Vermersch (France) 11.30 Coffee break 3
SESSION II MS Diagnosis and prognosis X. Montalban (Spain) 12.00 L6 McDonald criteria 2010: making the diagnosis easier A.J. Thompson (UK) 12.30 L7 The diagnosis of MS before MS M. Tintorè (Spain) 13.00 L8 What MRI is telling us about individual disease evolution? D. Arnold (Canada) 13.30 Lunch 14.30 C1 Case study: Differential diagnosis: NMO vs MS Presenter: speaker to be confirmed Discussants: L. Moiola (Italy) and B. Kieseier (Germany) SESSION III Treatment monitoring 15.10 L9 Biomarkers G. Giovannoni (UK) 15.40 L10 MRI as a potential marker of response A. Rovira (Spain) 16.10 L11 Present and future roles of PGX J. Oksenberg (USA) 16.40 Coffee break 17.00 L12 Assessment of treatment response M. S. Freedman (Canada) 17.30 C2 Case study: Treatment and treatment algorithms Presenter: G. Comi (Italy) Discussant: X. Montalban (Spain) 18.10 End of the day 4
Day 2 Saturday, 19 May, 2012 SESSION IV From disease management to patient management G. Comi (Italy) 09.00 L13 The patient s willingness to take risk B. Kieseier (Germany) 09.30 L14 How to implement the partnership in clinical practice D. Langdon (UK) 10.00 L15 Treatment adherence: how to measure it and how to improve it J. Sastre-Garriga (Spain) 10.30 C3 Case study: Treatment failure due to lack of adherence Presenter: speaker to be confirmed Discussants: P. Rieckmann (Germany) and J. Sastre-Garriga (Spain) 11.10 C4 Case study: How to improve outcomes tailoring treatment Presenter: D. Bates (UK) Discussants: G. Giovannoni (UK) and P. Vermersch (France) 11.50 Concluding remarks 12.10 End of the conference and closing lunch 5
Improving the patient s life through medical education www.seronosymposia.org Serono Symposia International Foundation Representative Office Salita di San Nicola da Tolentino 1/B 00187 Rome, Italy. T +39.(0)6.420.413.1, F +39.(0)6.420.413.677 Headquarters 14, Rue du Rhone, 1204 Geneva, Switzerland Copyright Serono Symposia International Foundation, 2012. All rights reserved.